Trial
NCT02795143
Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Toxic Epidermal Necrolysis
Intervention
Isotretinoin
Why stopped
PI (Responsible Party) transferred to new institution prior to enrollment and protocol was closed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-07